CD19 and B-cell non-Hodgkin lymphoma: Axicabtagene ciloleucel was one kind of autologous anti-CD19 CAR-T cell which consisted of CD28 transmembrane domain and CD28 costimulatory domain for patients with B-cell lymphoma.